Epaldeudomide

N/A

Report date: 2026/02/06 09:27:18
NME

Base Information

Drug NameEpaldeudomide
Drug Alias NameKPG-818
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCereblon modulatorsZinc finger protein Aiolos degradersDNA-binding protein Ikaros degraders
TargetsCereblonZinc finger protein AiolosDNA-binding protein Ikaros
Therapy Area/IndicationsLupus Erythematosus, SystemicHematologic NeoplasmsMultiple Myeloma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKangpu Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKangpu Biomedical Technology Co LtdKangpu Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicHematologic NeoplasmsMultiple Myeloma +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A